Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.
Conclusions None of the assessed biomarkers offer the ability to predict response to neoadjuvant CRT in patients with rectal cancer. They cannot therefore assist in identifying complete clinical or pathological responders who could be considered for a non-operative, observational approach.
PMID: 28462648 [PubMed - in process]
Source: Annals of the Royal College of Surgeons of England - Category: Surgery Authors: Clarke TL, White DA, Osborne ME, Shaw AM, Smart NJ, Daniels IR Tags: Ann R Coll Surg Engl Source Type: research
More News: Cancer | Cancer & Oncology | Hospital Management | MRI Scan | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rectal Cancers | Royal College of Surgeons | Study | Surgery